NCT03065868View on ClinicalTrials.gov

Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 9, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Gastric PolypHelicobacter Pylori Infection
Interventions
DRUG

H. pylori eradication (Amoxaxillin, Lanston, Clarithromycin)

H. pylori eradication (Triple Therapy) as first line treatment if eradication failure, quadruple therpy will be provided as 2nd line treatment

Trial Locations (1)

41404

Su Youn Nam, Daegu

All Listed Sponsors
lead

Kyungpook National University Hospital

OTHER

NCT03065868 - Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp | Biotech Hunter | Biotech Hunter